Most laboratory leaders understand that specimen redraws are undesirable.
They inconvenience patients.
Delay testing.
Create additional work for clinical staff.
But what many organizations don't fully appreciate is the true cost of a redraw.
Because the cost isn't simply collecting another specimen.
A redraw often represents the result of an earlier operational failure.
And when you begin looking beyond the collection itself, the financial and clinical impact becomes much larger.
A Redraw Starts Long Before the Patient Returns
When patients are asked to return for another blood draw or specimen collection, the redraw often feels like the beginning of the problem.
In reality, it's usually the final consequence.
Something happened earlier.
Perhaps the specimen wasn't transported correctly.
Maybe it experienced a temperature excursion.
Perhaps it was left behind after a missed pickup.
Or maybe it never reached the laboratory at all.
By the time the patient is called back, multiple operational failures may have already occurred.
The Direct Costs Are Easy to See
Most organizations recognize the immediate expenses associated with a redraw.
These often include:
- Additional collection supplies
- Nursing or phlebotomy time
- Registration and administrative work
- Laboratory processing
- Courier transportation
Those costs are relatively straightforward to calculate.
The larger costs are often hidden.
The Hidden Costs Most Laboratories Never Measure
A specimen redraw creates ripple effects throughout the healthcare system.
Staff Time
A redraw rarely happens automatically.
Someone must:
- Investigate what happened
- Notify the provider
- Contact the patient
- Schedule another appointment
- Prepare for another collection
Each step requires staff time that is rarely assigned to laboratory logistics.
Delayed Clinical Decisions
Until a replacement specimen is collected and processed, testing cannot move forward.
That delay may postpone:
- Diagnosis
- Treatment decisions
- Follow-up appointments
- Clinical planning
Transportation delays quickly become patient care delays.
Patient Frustration
Most patients assume one specimen collection is enough.
Being asked to return can create:
- Frustration
- Lost work time
- Additional travel
- Reduced confidence in the healthcare experience
For patients managing chronic illnesses or complex conditions, redraws create an unnecessary burden.
Sometimes the Problem Starts With a Missed Pickup
One of the simplest examples illustrates how easily redraws can occur.
A courier arrives for a routine specimen pickup.
The lockbox appears empty.
Without confirming whether additional specimens are still being prepared, the courier leaves.
A few minutes later, clinic staff place the day's specimens into the lockbox.
The courier is already gone.
The specimens remain overnight and may no longer be suitable for testing.
The next day, the patient must return.
What seemed like a minor communication breakdown has now affected multiple people and delayed care.
Some Specimens Can't Simply Be Collected Again
For many routine laboratory tests, a redraw is inconvenient.
For other specimens, it may be much more serious.
Bone marrow collections are invasive and often painful for patients.
Biopsy specimens may represent tissue collected during surgery or procedures that cannot simply be repeated without additional medical intervention.
In these situations, protecting the specimen throughout transportation becomes just as important as collecting it correctly.
Prevention Is Less Expensive Than Recovery
Every redraw requires resources.
But preventing redraws often begins with improving transportation visibility.
Organizations that strengthen their logistics processes may reduce redraws by focusing on:
- Reliable pickup procedures
- Clear communication between collection sites and couriers
- Chain-of-custody documentation
- Temperature-controlled transportation
- Real-time delivery visibility
- Performance monitoring
The goal isn't simply moving specimens.
It's ensuring specimens arrive at the laboratory in the condition needed for testing.
What Redraws Can Teach You
Every redraw represents an opportunity to ask better questions.
Instead of asking:
"Why did the patient need another collection?"
Ask:
- Was the specimen picked up on time?
- Was transportation delayed?
- Were temperature requirements maintained?
- Was chain of custody documented?
- Could this situation have been prevented?
Looking upstream often reveals opportunities to improve the logistics process itself.
The Better Question
Most organizations view redraws as a laboratory issue.
A better perspective is to view them as an operational indicator.
Because every redraw has a story.
Understanding that story helps laboratories identify weaknesses in their transportation processes before similar issues occur again.
Final Thought
Redraws are expensive.
Not simply because another specimen must be collected.
But because they affect patients, providers, laboratory staff, operational workflows, and healthcare resources.
The strongest laboratory logistics programs don't simply react to redraws.
They work to understand why they happened in the first place.
Because every prevented redraw represents:
- Better patient experiences
- More efficient laboratory operations
- Lower operational costs
- Greater confidence in the diagnostic process
Transportation may be only one part of the laboratory workflow.
But when it works well, patients rarely notice.
When it doesn't, everyone does.
Frequently Asked Questions
What is a specimen redraw?
A specimen redraw occurs when a patient must provide another specimen because the original sample could not be used for testing due to issues such as transportation delays, handling problems, or specimen integrity concerns.
What causes specimen redraws?
Common causes include missed pickups, transportation delays, temperature-control failures, specimen handling errors, labeling issues, and compromised specimen integrity.
Why are specimen redraws expensive?
In addition to collection costs, redraws require administrative coordination, clinical staff time, repeat transportation, delayed testing, and additional patient appointments.
How do redraws affect patients?
Patients may experience delayed diagnoses, additional travel, missed work, repeated procedures, and increased frustration with their healthcare experience.
Can transportation problems lead to specimen redraws?
Yes. Missed pickups, improper handling, delayed deliveries, or temperature-control issues can all contribute to specimens becoming unsuitable for testing.
Why are biopsy and bone marrow specimens especially critical?
These specimens may be difficult or impossible to replace without repeating invasive procedures, making proper transportation and handling essential.
How can laboratories reduce specimen redraws?
Improving pickup procedures, strengthening chain-of-custody documentation, maintaining temperature requirements, monitoring logistics performance, and improving communication between collection sites and couriers can all help reduce redraws.
What can laboratories learn from specimen redraws?
Redraws often reveal opportunities to improve transportation processes, operational visibility, and specimen handling before similar issues occur again.
